KEYSTONE 2015
Recent articles
Repurposed drugs may treat Angelman syndrome
An acne drug, a dietary supplement and a failed sleeping aid each show promise for Angelman syndrome, according to unpublished results presented Tuesday at a meeting.
Repurposed drugs may treat Angelman syndrome
An acne drug, a dietary supplement and a failed sleeping aid each show promise for Angelman syndrome, according to unpublished results presented Tuesday at a meeting.
Explore more from The Transmitter
Organoids and assembloids offer a new window into human brain
These sophisticated 3D cultures reveal previously inaccessible stages of human brain development and enable the systematic study of disease genes.
Organoids and assembloids offer a new window into human brain
These sophisticated 3D cultures reveal previously inaccessible stages of human brain development and enable the systematic study of disease genes.
Who funds your basic neuroscience research? Help The Transmitter compile a list of funding sources
We want to hear from you about the sources of funding for your research.
Who funds your basic neuroscience research? Help The Transmitter compile a list of funding sources
We want to hear from you about the sources of funding for your research.
The future of neuroscience research at U.S. minority-serving institutions is in danger
Cuts to federally funded programs present an existential crisis for the University of Puerto Rico’s rich neuroscience community and for research at minority-serving institutions everywhere.
The future of neuroscience research at U.S. minority-serving institutions is in danger
Cuts to federally funded programs present an existential crisis for the University of Puerto Rico’s rich neuroscience community and for research at minority-serving institutions everywhere.